Business
Wegovy-maker Novo Nordisk warns of 'painful' price cuts as shares slump
Novo Nordisk is facing "unprecedented" price pressures, "intensifying competition" and patents expiring. Source link
Tag
Novo
Business
‘Treating obesity for the next 100 years’: Ozempic-maker Novo Nordisk targets tripling of Apac patient base
By sales volumes for its GLP-1 drugs, the company’s largest markets in the region are Australia, Japan, South Korea and India With…
Business
European shares close at fresh record high as Novo Nordisk drives healthcare boost
EUROPEAN shares closed at a new peak on Tuesday, powered by gains in the healthcare sector, after heavyweight Novo Nordisk clinched US…
Business
Novo Nordisk shares jump almost 8% after US approves Wegovy pill
The approval gives the drugmaker a first-mover advantage in the race for a potent oral weight-loss medicine [COPENHAGEN/LONDON] Novo…
Business
Novo Nordisk stock slides as its Alzheimer’s drug trials fail
Novo Nordisk’s closely-watched Alzheimer’s trials of an older oral version of its semaglutide drug failed to help slow the progression of…
News
GLP-1 price war heats up as Novo Nordisk offers $199 starter doses
Novo Nordisk, the Danish drug company that makes Ozempic and Wegovy, is now offering the drugs at lower prices for self-pay patients. On…
Business
Novo gets 15 billion euros of orders for Akero acquisition bonds
Novo Nordisk has pulled in more than 15 billion euros (S$22.6 billion) of investor orders for its multi-tranche bond sale, more than…
News
Trump unveils deal with Eli Lilly and Novo Nordisk to lower costs and expand coverage for obesity drugs
President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their…
Business
Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid
Pfizer on Friday (Oct 31) filed a lawsuit against Metsera and Novo Nordisk, saying Metsera breached its merger agreement obligations in…
Business
Wegovy-maker Novo Nordisk to cut 9,000 jobs in restructuring
Wegovy-maker Novo Nordisk will cut 9,000 jobs, or about 11.5 per cent of its workforce, in a restructuring to save eight billion Danish…
Business
Ozempic-maker Novo Nordisk to cut 9,000 jobs in restructuring
Wegovy-maker Novo Nordisk will cut 9,000 jobs, or about 11.5 per cent of its workforce, in a restructuring to save eight billion Danish…
Business
Europe: Stoxx 600 ends higher on defence boost; Novo Nordisk jumps after Wegovy data
European shares finished marginally higher on Monday (Sep 1), supported by defence stocks, while Novo Nordisk gained after data showed its…
Business
Why is GDRX stock up today? GoodRx strikes deal to sell Ozempic and Wegovy after Novo Nordisk’s breakup with Hims
Share prices of GoodRx (NASDAQ: GDRX), the American healthcare company and telemedicine service, are currently soaring after the company…
Business
Singapore’s KPB Biosciences fails in bid to unfreeze assets in US$830 million Novo Nordisk legal battle
Locally headquartered biotech firm KPB Biosciences has failed to set aside a court order for its assets to be frozen, with the Singapore…
Business
Eli Lilly is giving Novo Nordisk a run for its money—so why is LLY stock still down today?
It’s been a week of wins for Eli Lilly’s weight-loss drugs. In the company’s second quarter earnings report on Thursday, it reported that…
Business
NVO stock: Why did Novo Nordisk shares drop 20% today—and who is Maziar Mike Doustdar?
Health-related stocks are not having a good day. First, America’s largest health insurance provider, UnitedHealth Group (NYSE: UNH), saw…
Business
Hims & Hers stock plummets after Novo Nordisk ends partnership over “knock-off” Wegovy
This morning, the Danish pharmaceutical giant Novo Nordisk announced the abrupt end of its brief partnership with telehealth company Hims…
Business
Novo Nordisk overtakes SAP as Europe’s most valuable company
Novo Nordisk reclaimed its position as Europe’s most valuable public company, overtaking software developer SAP. Shares in the Danish…
Business
Novo Nordisk posts strong Q1 as weight-loss revolution claims another victim: WeightWatchers
One day after WeightWatchers said that it would file for bankruptcy, weight loss drug giant Novo Nordisk’s outlook is brightening. Novo…
News
Novo Nordisk latest drugmaker to drop gender goals in US
This follows executive orders by President Donald Trump to stop diversity, equity and inclusion initiatives Obesity drugmaker Novo Nordisk…
Business
Hims & Hers stock price soars after partnership with Novo Nordisk to offer weight-loss drug Wegovy
Shares in Hims & Hers Health, Inc. (NYSE: HIMS) are skyrocketing in early-morning trading today after the telehealth company announced a…
Business
Novo seeks US$830 million from Singapore firm, accusing it of fraud over drug
Novo Nordisk is seeking as much as US$830 million in damages in a Singapore court, saying it was misled by a local biotech about the…
Business
All assets of biotech founder in Novo Nordisk suit frozen, including US$218 million in DBS account
The Danish drugmaker alleges misrepresentations by KBP Biosciences founder Huang Zhenhua about the success of its kidney drug PHARMA giant…
Business
Europe: Stoxx 600 inches up as Novo Nordisk surges at start of Christmas week
EUROPE’S Stoxx 600 closed slightly higher at the start of a holiday-shortened week, as a spike in Novo Nordisk shares boosted the…